Zentalis Pharmaceuticalsllc Stock Net Income
| ZNTL Stock | USD 13.00 0.04 0.31% |
Zentalis PharmaceuticalsLlc fundamentals help investors to digest information that contributes to Zentalis PharmaceuticalsL's financial success or failures. It also enables traders to predict the movement of Zentalis Stock. The fundamental analysis module provides a way to measure Zentalis PharmaceuticalsL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zentalis PharmaceuticalsL stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -286.4 M | -272 M | |
| Net Loss | -213.1 M | -202.5 M | |
| Net Loss | -292.2 M | -277.6 M | |
| Net Loss | (4.47) | (4.69) | |
| Net Income Per E B T | 1.06 | 0.79 |
Zentalis | Net Income |
Zentalis PharmaceuticalsLlc Company Net Income Analysis
Zentalis PharmaceuticalsL's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Zentalis PharmaceuticalsL Net Income | (292.19 M) |
Most of Zentalis PharmaceuticalsL's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zentalis PharmaceuticalsLlc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Zentalis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Zentalis PharmaceuticalsL is extremely important. It helps to project a fair market value of Zentalis Stock properly, considering its historical fundamentals such as Net Income. Since Zentalis PharmaceuticalsL's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zentalis PharmaceuticalsL's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zentalis PharmaceuticalsL's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Zentalis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Zentalis PharmaceuticalsLlc reported net income of (292.19 Million). This is 185.62% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 151.17% higher than that of the company.
Zentalis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zentalis PharmaceuticalsL's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zentalis PharmaceuticalsL could also be used in its relative valuation, which is a method of valuing Zentalis PharmaceuticalsL by comparing valuation metrics of similar companies.Zentalis PharmaceuticalsL is currently under evaluation in net income category among related companies.
Zentalis PharmaceuticalsL Institutional Holders
Institutional Holdings refers to the ownership stake in Zentalis PharmaceuticalsL that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zentalis PharmaceuticalsL's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zentalis PharmaceuticalsL's value.| Shares | Decheng Capital Llc | 2023-12-31 | 2.1 M | Woodline Partners Lp | 2023-12-31 | 1.4 M | Geode Capital Management, Llc | 2023-12-31 | 1.3 M | Primecap Management Company | 2023-12-31 | 1 M | Tybourne Capital Management (hk) Ltd | 2023-12-31 | 961.5 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 724 K | Bank Of America Corp | 2023-12-31 | 718.6 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 609.5 K | Goldman Sachs Group Inc | 2023-12-31 | 585.8 K | Matrix Capital Management Company, Llc | 2023-12-31 | 14 M | Eventide Asset Management, Llc | 2023-12-31 | 11.6 M |
Zentalis Fundamentals
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 485.44 M | ||||
| Shares Outstanding | 70.96 M | ||||
| Shares Owned By Insiders | 4.27 % | ||||
| Shares Owned By Institutions | 95.73 % | ||||
| Number Of Shares Shorted | 15.53 M | ||||
| Price To Book | 2.18 X | ||||
| EBITDA | (252.55 M) | ||||
| Net Income | (292.19 M) | ||||
| Cash And Equivalents | 455.22 M | ||||
| Cash Per Share | 7.99 X | ||||
| Total Debt | 45.77 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 9.61 X | ||||
| Book Value Per Share | 6.18 X | ||||
| Cash Flow From Operations | (207.82 M) | ||||
| Short Ratio | 16.26 X | ||||
| Earnings Per Share | (4.47) X | ||||
| Target Price | 34.4 | ||||
| Number Of Employees | 124 | ||||
| Beta | 1.73 | ||||
| Market Capitalization | 922.48 M | ||||
| Total Asset | 562.03 M | ||||
| Retained Earnings | (888.56 M) | ||||
| Working Capital | 427.35 M | ||||
| Net Asset | 562.03 M |
About Zentalis PharmaceuticalsL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zentalis PharmaceuticalsLlc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zentalis PharmaceuticalsL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zentalis PharmaceuticalsLlc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zentalis PharmaceuticalsL in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zentalis PharmaceuticalsL's short interest history, or implied volatility extrapolated from Zentalis PharmaceuticalsL options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports:Check out Zentalis PharmaceuticalsL Piotroski F Score and Zentalis PharmaceuticalsL Altman Z Score analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.